#DeathCross $MACK at 4.33 R15 HiLo 48% T1Y 4 hold 3.5 fwdPE -2.4 DIV N/A #Merrimack #stocks #trading #finance #market

2019-10-11
116 Views

Death Cross detected for MACK (Merrimack Pharmaceut) at the close price of 4.33. Trading at a 48 % level between the 52week High (6.19) and 52week Low (2.63).
The average analyst 1-year target price is 4.0 with an average hold and a score of 3.5.

Death Cross
15 %
MACK
4.33
Merrimack Pharmaceut
HiLo
47.8 pc
Support
4.33
Resistance
5.07
50DMA
5.83
200DMA
5.85
52week high
6.19
52week low
2.63
10DMA
4.54
20DMA
5.02
100 Mean
5.83
Volume
71526
AvgDayVol
84681
MarketCap
57861788
EBITDA
-41476000
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date
2019-09-06 00:00:00

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance
Global Indicators,
1 views
Global Indicators,
1 views

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance
Global Indicators,
1 views
Global Indicators,
1 views

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance
Global Indicators,
6 views
Global Indicators,
6 views

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.